1. Home
  2. EMBC vs AMLX Comparison

EMBC vs AMLX Comparison

Compare EMBC & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • AMLX
  • Stock Information
  • Founded
  • EMBC 1924
  • AMLX 2014
  • Country
  • EMBC United States
  • AMLX United States
  • Employees
  • EMBC N/A
  • AMLX N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • AMLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EMBC Health Care
  • AMLX Health Care
  • Exchange
  • EMBC Nasdaq
  • AMLX Nasdaq
  • Market Cap
  • EMBC 726.8M
  • AMLX 684.6M
  • IPO Year
  • EMBC N/A
  • AMLX 2022
  • Fundamental
  • Price
  • EMBC $9.96
  • AMLX $7.72
  • Analyst Decision
  • EMBC Buy
  • AMLX Strong Buy
  • Analyst Count
  • EMBC 2
  • AMLX 7
  • Target Price
  • EMBC $19.00
  • AMLX $12.00
  • AVG Volume (30 Days)
  • EMBC 526.4K
  • AMLX 1.5M
  • Earning Date
  • EMBC 08-08-2025
  • AMLX 08-07-2025
  • Dividend Yield
  • EMBC 5.91%
  • AMLX N/A
  • EPS Growth
  • EMBC N/A
  • AMLX N/A
  • EPS
  • EMBC 0.89
  • AMLX N/A
  • Revenue
  • EMBC $1,079,500,000.00
  • AMLX N/A
  • Revenue This Year
  • EMBC N/A
  • AMLX N/A
  • Revenue Next Year
  • EMBC N/A
  • AMLX N/A
  • P/E Ratio
  • EMBC $11.39
  • AMLX N/A
  • Revenue Growth
  • EMBC N/A
  • AMLX N/A
  • 52 Week Low
  • EMBC $9.20
  • AMLX $1.76
  • 52 Week High
  • EMBC $21.48
  • AMLX $8.72
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 43.81
  • AMLX 54.70
  • Support Level
  • EMBC $9.68
  • AMLX $7.84
  • Resistance Level
  • EMBC $11.79
  • AMLX $8.29
  • Average True Range (ATR)
  • EMBC 0.51
  • AMLX 0.45
  • MACD
  • EMBC -0.05
  • AMLX -0.13
  • Stochastic Oscillator
  • EMBC 22.12
  • AMLX 2.90

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Share on Social Networks: